Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway

Journal of Hepatology

Volumn 43, Issue 1, 2005, Pages 85-91

  Morales Ruiz, Manuel ^a   Tugues, Sònia ^a   Cejudo Martín, Pilar ^a   Ros, Josefa ^a   Melgar Lesmes, Pedro ^a   Fernández Llama, Patricia ^b   Arroyo, Vicente ^a   Rodés, Juan ^a   Jiménez, Wladimiro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Akt; Angiogenesis; Ascites; Cirrhosis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; FIBRONECTIN ANTIBODY; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN ANTIBODY; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIBODY RESPONSE; ARTICLE; ASCITES; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VIVO STUDY; LIVER CIRRHOSIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIBODIES; ASCITES; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; CHICK EMBRYO; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBRONECTINS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER CIRRHOSIS; MALE; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 20444410027     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.01.035     Document Type: Article

References (29)

1. K.P. Moore, F. Wong, P. Gines, M. Bernardi, A. Ochs, and F. Salerno The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club Hepatology 38 2003 258 266
2. J.C. Hoefs Characteristics of Ascites V. Arroyo P. Gines J. Rodes R.W. Schrier Ascites and renal dysfunction in liver disease: pathogenesis, diagnosis and treatment 1999 Blackwell Science, Inc. Malden, MA 14 35
3. K. Jin-no, M. Tanimizu, I. Hyodo, F. Kurimoto, and T. Yamashita Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease J Gastroenterol 32 1997 119 121
4. R.C. Mesquita, M.M. Leite-Mor, and E.R. Parise Fibronectin in the ascitic fluid of cirrhotic patients: correlation with biochemical risk factors for the development of spontaneous bacterial peritonitis Braz J Med Biol Res 30 1997 843 847
5. M. Navasa, A. Follo, X. Filella, W. Jimenez, A. Francitorra, and R. Planas Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality Hepatology 27 1998 1227 1232
6. I. Shimizu, A. Ichihara, and T. Nakamura Hepatocyte growth factor in ascites from patients with cirrhosis J Biochem (Tokyo) 109 1991 14 18
7. P. Cejudo-Martin, J. Ros, M. Navasa, J. Fernandez, G. Fernadez-Varo, and L. Ruiz-del-Arbol Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis Hepatology 34 2001 487 493
8. P. Cejudo-Martin, M. Morales-Ruiz, J. Ros, M. Navasa, G. Fernandez-Varo, and J. Fuster Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients Hepatology 36 2002 1172 1179
9. M. Perez-Ruiz, J. Ros, M. Morales-Ruiz, M. Navasa, J. Colmenero, and L. Ruiz-del-Arbol Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide Hepatology 29 1999 1057 1063
10. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, and K. Walsh Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
11. J.P. Gratton, M. Morales-Ruiz, Y. Kureishi, D. Fulton, K. Walsh, and W.C. Sessa Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells J Biol Chem 276 2001 30359 30365
12. M.J. Lee, S. Thangada, J.H. Paik, G.P. Sapkota, N. Ancellin, and S.S. Chae Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis Mol Cell 8 2001 693 704
13. M. Morales-Ruiz, D. Fulton, G. Sowa, L.R. Languino, Y. Fujio, and K. Walsh Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt Circ Res 86 2000 892 896
14. M. Morales-Ruiz, M.J. Lee, S. Zollner, J.P. Gratton, R. Scotland, and I. Shiojima Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells J Biol Chem 276 2001 19672 19677
15. J. Ros, A. Leivas, W. Jimenez, M. Morales, M. Bosch-Marce, and V. Arroyo Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells J Hepatol 26 1997 81 87
16. M. Morales-Ruiz, P. Cejudo-Martin, G. Fernandez-Varo, S. Tugues, J. Ros, and P. Angeli Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats Gastroenterology 125 2003 522 531
17. Y. Fujio, and K. Walsh Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner J Biol Chem 274 1999 16349 16354
18. P.J. Margetts, M. Kolb, L. Yu, C.M. Hoff, C.J. Holmes, and D.C. Anthony Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum Am J Pathol 160 2002 2285 2294
19. T. Miyata, O. Devuyst, K. Kurokawa, and dS van Ypersele Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes Kidney Int 61 2002 375 386
20. Z. Luo, Y. Fujio, Y. Kureishi, R.D. Rudic, G. Daumerie, and D. Fulton Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo J Clin Invest 106 2000 493 499
21. I. Shiojima, and K. Walsh Role of Akt signaling in vascular homeostasis and angiogenesis Circ Res 90 2002 1243 1250
22. J. Gu, A. Fujibayashi, K.M. Yamada, and K. Sekiguchi Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways J Biol Chem 277 2002 19922 19928
23. Q. Zeng, S. Chen, Z. You, F. Yang, T.E. Carey, and D. Saims Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B J Biol Chem 277 2002 25203 25208
24. L.T. Sumanovski, E. Battegay, M. Stumm, K.M. van der, and C.C. Sieber Increased angiogenesis in portal hypertensive rats: role of nitric oxide Hepatology 29 1999 1044 1049
25. M. Fernandez, F. Vizzutti, J.C. Garcia-Pagan, J. Rodes, and J. Bosch Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice Gastroenterology 126 2004 886 894
26. J. Ros, J. Claria, J. To-Figueras, A. Planaguma, P. Cejudo-Martin, and G. Fernandez-Varo Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat Gastroenterology 122 2002 85 93
27. R. Wiest, and R.J. Groszmann The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough Hepatology 35 2002 478 491
28. A. Castro, W. Jimenez, J. Claria, J. Ros, J.M. Martinez, and M. Bosch Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide Hepatology 18 1993 367 372
29. G. Fernandez-Varo, J. Ros, M. Morales-Ruiz, P. Cejudo-Martin, V. Arroyo, and M. Sole Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis Am J Pathol 162 2003 1985 1993